{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:23Z","timestamp":1786115063594,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V009605\/1"],"award-info":[{"award-number":["MR\/V009605\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A28890"],"award-info":[{"award-number":["A28890"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RCCPOB-Nov22\/100010"],"award-info":[{"award-number":["RCCPOB-Nov22\/100010"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijrobp.2026.02.203","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:51:05Z","timestamp":1771260665000},"page":"1506-1511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sacubitril\/Valsartan as a Cardiac Radioprotector"],"prefix":"10.1016","volume":"125","author":[{"given":"Mihaela","family":"Ghita-Pettigrew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna N.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn H.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narainrit","family":"Karuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Herron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin Suguna","family":"Seelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Harbinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Greystoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl T.","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-9732","authenticated-orcid":false,"given":"Gerard M.","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.203_bib0001","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41416-024-02888-0","article-title":"Cardiotoxicity following thoracic radiotherapy for lung cancer","volume":"132","author":"Walls","year":"2025","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001072","article-title":"Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: Comparison with B-type natriuretic peptide and other natriuretic peptide forms","volume":"6","author":"Takashio","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0003","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1074248420952243","article-title":"The role of natriuretic peptides in the regulation of cardiac tolerance to ischemia\/reperfusion and postinfarction heart remodeling","volume":"26","author":"Krylatov","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/095530096145337","article-title":"Changes in myocardial and circulating atrial natriuretic peptide following thorax irradiation in rat","volume":"70","author":"Persons","year":"1996","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0006","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09553000110102021","article-title":"Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart","volume":"78","author":"Kruse","year":"2002","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0007","article-title":"A multimodality assessment of the protective capacity of statin therapy in a mouse model of radiation cardiotoxicity","volume":"190","author":"Walls","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0008","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0009","article-title":"BNP as a potential biomarker for cardiac damage of breast cancer after radiotherapy: A meta-analysis","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0010","first-page":"61","article-title":"A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer","volume":"25","author":"Walls","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtho.2020.11.002","article-title":"Cardiac toxicity of thoracic radiotherapy: Existing evidence and future directions","volume":"16","author":"Banfill","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0013","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2023.08.011","article-title":"Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy","volume":"118","author":"Miller","year":"2024","journal-title":"Int J Radiat Oncol Biol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0014","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijrobp.2022.08.013","article-title":"Cardiac substructures dosimetric predictors for cardiac toxicity after definitive radiotherapy in esophageal cancer","volume":"115","author":"Cai","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0016","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S1470-2045(19)30519-4","article-title":"Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): A randomised, controlled, phase 3 study","volume":"20","author":"Hui","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0017","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","article-title":"Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer","volume":"128","author":"Contreras","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1007577","article-title":"Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer","volume":"12","author":"Banfill","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0019","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: Combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.peptides.2018.05.012","article-title":"Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides (NY)","volume":"111","author":"Nakagawa","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0021","series-title":"Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (TA388)","year":"2016"},{"key":"10.1016\/j.ijrobp.2026.02.203_bib0022","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3892\/ol.2023.13694","article-title":"Effectiveness of sacubitril\/valsartan for patients with cancer therapyrelated cardiac dysfunction: A systematic review of descriptive studies","volume":"25","author":"Huang","year":"2023","journal-title":"Oncol Lett"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:39Z","timestamp":1785974439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0360301626003925"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.203","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\/Valsartan as a Cardiac Radioprotector","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}